9
landing page
Center for Public Health Advisory Board
Paul Chew
President, 1Rx DigiPharm Advisory, LLC
report
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials
FasterCures has initiated a body of work to advance system change within biomedical research to foc
us on and value diversity and representation within clinical trials.
+ Read More
report
A Global Early Warning System for Pandemics: A Blueprint for Coordination
The COVID-19 pandemic has had enormous health, social, and economic consequences.
report
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to id
report
Coalition-Building between the US and China on Women’s Cancer Detection, Treatment, and Care
Cancer is one of the leading causes of death in the US and China. Of the top 10 (by incidence) canc
ers in China, four are women’s cancers, including breast and cervical cancers.
+ Read More
article
An Update from MI Health—July 2024
In This Issue:
article
FasterCures Quarterly Update—July 2024
In This Newsletter
Highlights from Global Conference
Recent Publications
Policy Updates
FasterCures
Program Updates
+ Read More
article
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
The Milken Institute celebrates the publication of the second iteration of the Food and Drug Adminis
tration (FDA) draft guidance on Diversity Action Plans (DAP) to improve clinical trial diversity by enrolling underrepresented populations in the US.
+ Read More
article
2023-2026 National Health Security Strategy (NHSS) Comment Letter
Submitted electronically
Ms. Dawn O’Connell
Assistant Secretary for Preparedness and Response
HHS O
ffice of the Assistant Secretary for Preparedness and Response (ASPR)
200 Independence Ave.
Washington, DC 20201
+ Read More